Roth MKM analyst Suji Desilva lowered the firm’s price target on Rocket Lab (RKLB) to $7 from $10 but keeps a Buy rating on the shares. The company’s Q3 revenue growth was in line, with growth coming in space systems offsetting a mild pause in launch, the analyst tells investors in a research note. The firm adds however that it expects a healthy launch revenue recovery in the early 2024 as Rocket Lab recovers from its recent flight anomaly, as well as strong space systems ramp driven by contribution from a large spacecraft contract with Globalstar (GSAT).
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on RKLB:
- Rocket Lab sees Q4 revenue $65M-$69M, consensus $85.22M
- Rocket Lab reports Q3 EPS (8c), consensus (9c)
- Microsoft upgraded, F5 Networks downgraded: Wall Street’s top analyst calls
- Cantor starts Rocket Lab with Overweight on ‘proven’ track record
- Rocket Lab initiated with an Overweight at Cantor Fitzgerald